Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Cuenca-Zamora EJ, Martinez C, Morales ML, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Alcolea-Guardiola C, Vidal-Garrido N, Lozano ML, Gonzalez-Conejero R, Teruel-Montoya R, Ferrer-Marin F. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model. Biomed Pharmacother. 2024 Dec;181:117712. doi: 10.1016/j.biopha.2024.117712. Epub 2024 Nov 26. PubMed PMID: 39603040.
AÑO: 2024; IF: 7.5
Labrador J, Martinez-Cuadron D, Boluda B, Serrano J, Gil C, Perez-Simon JA, Bernal T, Bergua JM, Martinez-Lopez J, Rodriguez-Medina C, Vidriales MB, Garcia-Boyero R, Algarra L, Polo M, Sayas MJ, Tormo M, Alonso-Dominguez JM, Herrera P, Lavilla E, Ramos F, Amigo ML, Vives-Polo S, Rodriguez-Macias G, Mena-Duran A, Perez-Encinas MM, Arce-Fernandez O, Cuello R, Sanchez-Garcia J, Gomez-Casares MT, Chillon MC, Calasanz MJ, Ayala R, Rodriguez-Veiga R, Barragan E, Montesinos P; PETHEMA Group. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry. Cancer. 2024 Oct 15;130(20):3436-3451. doi: 10.1002/cncr.35431. Epub 2024 Jun 19. PubMed PMID: 38896056.
AÑO: 2024; IF: 5.1
Segura-Diaz A, Stuckey R, Florido Y, Sobas M, Alvarez-Larran A, Ferrer-Marin F, Perez-Encinas M, Carreno-Tarragona G, Fox ML, Tazon Vega B, Cuevas B, Lopez Rodriguez JF, Sanchez-Farias N, Gonzalez-Martin JM, Gomez-Casares MT, Bilbao-Sieyro C; Spanish MPN Group (GEMFIN). DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study. Thromb Haemost. 2024 Jul;124(7):669-675. doi: 10.1055/a-2239-9265. Epub 2024 Jan 8. PubMed PMID: 38190984; PubMed Central PMCID: PMC11199052.
AÑO: 2024; IF: 4.3
Cruz-Castellanos P, Gil-Raga M, Jimenez-Fonseca P, Ghanem I, Hernandez R, Piera-Molons N, Cano JM, Gallego-Martinez A, Garcia-Torralba E, Calderon C. Uncertainty and hope in relation to anxiety and depression in advanced lung cancer. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e847-e850. doi: 10.1136/spcare-2022-003882. PubMed PMID: 36100428.
AÑO: 2024; IF: 1.8
Martinez-Cuadron D, Megias-Vericat JE, Gil C, Bernal T, Tormo M, Martinez-Sanchez P, Rodriguez-Medina C, Serrano J, Herrera P, Simon JAP, Sayas MJ, Bergua J, Lavilla-Rubira E, Amigo ML, Benavente C, Lorenzo JLL, Perez-Encinas MM, Vidriales MB, Colorado M, De Rueda B, Garcia-Boyero R, Marini S, Garcia-Suarez J, Lopez-Pavia M, Gomez-Roncero MI, Noriega V, Lopez A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Solana-Altabella A, Boluda B, Montesinos P. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry. Haematologica. 2024 Jan 1;109(1):115-128. doi: 10.3324/haematol.2022.282506. PubMed PMID: 37199127; PubMed Central PMCID: PMC10772508.
AÑO: 2024; IF: 7.9
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL